Kylin Expands Collaboration with Purdue to Test pRNA Tech in More Cancer Models

The move comes amid a slight change from the course Kylin had charted earlier this year when its top executive said that the company was planning to add as many as six new employees to handle additional in vivo research.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.